Viewing Study NCT05014412

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2026-04-16 @ 9:16 PM
Study NCT ID: NCT05014412
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-15
First Post: 2021-08-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BCMA View
None Multiple Myeloma View
None Relapse/Refractory View
None RRMM View
None Elranatamab View
None Targeted T-cell View
None MagnetisMM View
None MM9 View
None Phase 2 View
None B-Cell Maturation Antigen View
None monoclonal antibody View